14 Followers on Owler

Merus

is a clinical-stage immuno-oncology company that researches and develops bispecific antibody therapeutics for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights

Merus

is a clinical-stage immuno-oncology company that researches and develops bispecific antibody therapeutics for the treatment of cancer... Read more
Merus President & CEO: Bill Lundberg

President & CEO

Bill Lundberg

CEO Approval Rating

90/100

2003

PublicAcquisition Pending from Genmab A/SNASDAQMRUS

Pharmaceuticals & Biotechnology
Biotechnology
28368731 NAICS listing

Annual Revenue
$56.6M
Employees
260
Funding
$389M

News

Acquisition
Sep 29, 2025
globenewswire.com
Merus Was acquired by Genmab A/S for $8B

Merus Competitors

1Affimed
2Zymeworks
3CytomX
4ADC Therapeutics
5Meditope
6ADC Bio
7Novartis
8Amgen
9ImmunGene
10NexImmune
Unlock 22 + competitors

Trending Companies